Cross-talk between the phospholipase C and adenylyl cyclase signalling pathways was investigated in Chinese hamster ovary (CHO) cells transfected with the V "a and V # vasopressin receptors. Cell lines expressing V "a , V # , or both V "a and V # receptors, were established and characterized. Stimulation of V # receptors by vasopressin induced a dose-dependent increase in cAMP accumulation, whereas stimulation of V "a receptor resulted in an increase in intracellular calcium without any change in basal cAMP. The simultaneous stimulation of V # and V "a receptors by vasopressin elicited an intracellular cAMP accumulation which was twice that induced by stimulation of V # receptor alone with deamino-[-Arg)]vasopressin. This potentiation between V "a and V # receptors was mimicked by activation of protein kinase C
INTRODUCTION
The diversity of the signal transduction pathways linked to cell surface receptors raises the question of how these systems might relate to each other. With regard to the G-protein-coupled receptors, transmission of information is related to the interactions between ligands, receptors, G-proteins and enzymes that generate the second messengers. Different models for cross-talk at those different steps have been previously reviewed [1, 2] . For example, a single receptor may activate alternative signalling pathways through different G proteins [3, 4] ; different receptors may share the same G protein pool [5] ; second messengers may modulate their production of each other [6] .
As regards the latter possibility, intracellular cAMP levels may be modified by calcium through regulation of the activity of some adenylyl cyclase isozymes. Calcium stimulates types 1, 3 and 8 adenylyl cyclase isoforms, inhibits types 5 and 6, and has no effect on types 2, 4 and 7 [7] . Such regulation may occur through either extracellular calcium entry or intracellular calcium mobilization with or without association with calmodulin (CAM). Regulation of the adenylyl cyclase activity by protein kinase C (PKC) has also been described. Phosphorylation of type 2 adenylyl cyclase by PKC has been observed in different cell lines, where phorbol esters, known activators of PKC, potentiate both basal and forskolin (FSK)-stimulated cAMP production [8] [9] [10] . Similar results have been reported for type 3 and type 5 adenylyl cyclase isoforms [9, 11, 12] , whereas studies concerning the type 1 isoform have led to conflicting reports [9, 10] . Intracellular messengers may also regulate the cAMP at the level of the cAMP hydrolysis. The phosphodiesterase (PDE) type 1 isoform is activated by the calcium-calmodulin complex, whereas
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(PKC) with PMA, and was suppressed when PKC activity was inhibited by bisindolylmaleimide. The potentiation was observed in the presence or absence of 1 mM 3-isobutyl-1-methylxanthine, a phosphodiesterase inhibitor, implying that an alteration in cAMP hydrolysis was not involved. Vasopressin, as well as PMA, had no effect on the forskolin-induced cAMP accumulation, suggesting that PKC did not directly stimulate the cyclase activity. On the other hand, vasopressin, like PMA, potentiated the cAMP accumulation induced by cholera toxin, an activator of Gα s protein. These results suggest that, in CHO cells, vasopressin V "a receptor potentiates the cAMP accumulation induced by the V # receptor through a PKC-dependent increase in the coupling between Gs protein and adenylyl cyclase. type 2 and type 3 isoforms are respectively activated and inhibited by cGMP. The regulation of the two other cAMP-hydrolysing phosphodiesterases, type 4 and type 7 isoforms, is still unknown [13] .
Such cross-talk between phospholipase C (PLC) and adenylyl cyclase transduction pathways was investigated in CHO cells transfected with both the V "a and the V # vasopressin receptors. These two receptors have been identified as members of the G-protein-coupled receptor family [14, 15] . In CHO cells, their respective signal transduction pathway is similar to the one described in native tissues. The stimulation of the V "a receptor results in the activation of phospholipase C β , and consequently in diacylglycerol (DAG) formation, inositol triphosphate generation and intracellular calcium mobilization. The V # receptor is coupled to a G s protein and activates the adenylyl cyclase, which results in cAMP production [16] .
We found that the V # -induced cAMP accumulation was potentiated by the stimulation of the V "a receptor transduction pathway. This potentiation occurs essentially via the PKC, which would possibly increase the coupling of the Gs protein with the adenylyl cyclase. Such a mechanism offers an additional regulatory step to the most currently described potentiating mechanisms, which imply the intrinsic adenylyl cyclase enzymatic activity or the phosphodiesterase activity.
EXPERIMENTAL Materials
Ham's F-12 medium, fetal bovine serum (FBS) and penicillinstreptomycin were obtained from Gibco-BRL ; hygromycin B was from Boehringer-Mannheim. Vasopressin and deamino-[-Arg)]vasopressin (dDAVP) were from Neosystem, [$H]vasopressin was from DuPont-NEN, bestatin, 3-isobutyl 1-methylxanthine (IBMX), BSA, PMA, 4α-phorbol 12,13-didecanoate (αPDD) were from Sigma, BAPTA-AM was from Calbiochem, cholera toxin and pertussis toxin were from Biomol, fura-2 was from Molecular Probes and cAMP enzymatic immunoassay was from Cayman Chemical. SR 49059 was a gift from Sanofi.
Cell culture
CHO cells were maintained at 37 mC in a humidified 5 % CO # atmosphere in Ham's F-12 medium (with glutamine) supplemented with 10 % FBS, 10 units\ml penicillin-streptomycin, and with 350 µg\ml hygromycin for transfected cells. Media were changed every 2 days and subculture was performed by trypsinization. After transfection, cells were used between passages 4 and 40.
Construction of CHO cell lines stably expressing rat V 1a and/or V 2 receptor pCD SP6\T7 vector containing the V "a cDNA [11] , and pECE vector containing the V # cDNA, were either independently or simultaneously transfected into CHO cells by the calcium phosphate precipitation method, in the presence of a hygromycin resistance vector. Hygromycin-resistant clones were tested for V "a and\or V # mRNA expression by RT-PCR using the primers described by Firsov et al. [17] . The positive clones were grown and tested for cAMP production. The expression of the vasopressin receptors on cell lines was also tested by binding studies, and pure clones were obtained by the limiting dilution technique.
Radioligand binding assays
Radioligand binding saturation assays were performed on confluent cells in 24- 
cAMP measurement
Experiments were performed in 24-well plates. Confluent cells were rinsed twice with PBS, and preincubated for 10 min at 37 mC in PBS in the presence of 1 mM MgCl # , 1 mM CaCl # (except in Ca# + -free experiments), 1 mM Hepes, 0n1 % BSA (w\v), 0n1 % bacitracin (w\v), 10 −' M bestatin and 5i10 −' M indomethacin, pH 7n4. When used, IBMX and EGTA were at a concentration of 1 mM. Preincubation medium was removed and cells were stimulated for 4 min at 37 mC with similar medium containing the studied effectors. Each set of conditions was performed in duplicate. Medium was removed at the end of the stimulating period, and cells were lysed by addition of 5 % ethanol\formic acid (v\v) which was thereafter collected and evaporated overnight. The cAMP content of each sample was determined by enzymatic immunoassay according to Pradelles et al. [19] .
Intracellular calcium measurement
Cells were grown to confluence in T #& flasks, trypsinized, centrifuged and incubated for 40 min with 2 µM fura-2 AM in culture medium supplemented with FBS. Cells were then centrifuged and resuspended at a concentration of 2 million cells per ml in PBS containing 1 mM MgCl # , 1 mM CaCl # , 1 mM Hepes, 0n1 % BSA, 0n1 % bacitracin, 10 −' M bestatin and 5i10 −' M indomethacin, pH 7n4. When used, EGTA was at a concentration of 1 mM. Calcium measurements were performed with 1 ml of the cell suspension using an Amincon Bowman SLM 2 spectrofluorimeter. Cells were alternatively excited at either 340 nm or 380 nm, and the fluorescence emission was recorded at 510 nm. The ratio, R, between 340\380 nm was calculated each 0n5 s. At the end of the experiment, cells were permeabilized with 30 µM digitonin and R min and R max were determined by addition of 12 mM EGTA and saturating calcium concentration. The intracellular calcium concentration was calculated according to the Grynkiewicz equation [20] .
Data are expressed as meanpS.E.M. The significance of the results was tested by ANOVA (Dunnett's test, P 0n05). dDAVP-induced cAMP accumulation or on the basal cAMP level ( Table 1) .
RESULTS

Expression of the vasopressin receptors in CHO cells
Involvement of calcium, DAG and protein kinase C in the potentiation by AVP of dDAVP-induced cAMP accumulation
The role of calcium in the potentiation was tested by incubating CHO V " V # cells in calcium-free medium supplemented with 1 mM EGTA and by addition of the intracellular calcium chelator BAPTA-AM at a concentration of 60 µM. The absence of extracellular Ca# + did not modify the dDAVP-induced cAMP accumulation and its potentiation by AVP (Table 2) . When intracellular calcium was chelated by 60 µM BAPTA-AM, the dDAVP-induced cAMP level was diminished and the potentiation was abolished (Table 2) . BAPTA-AM also decreased the cAMP accumulation induced by 5i10 −& M of the cyclase activator forskolin from 44n8p8n1 to 15n6p3n2 pmol\well. The relative implication of intracellular calcium and DAG was assessed by stimulating the cells with dDAVP and either thapsi- gargin, diacylglycerol analogue DOG, or both. DOG partially mimicked the effect of AVP on dDAVP-induced cAMP accumulation. Thapsigargin alone, which increases intracellular calcium [34] , did not potentiate cAMP accumulation, but enhanced the effect of DOG (Table 3 ). This suggests that DAG is the second messenger directly involved in the potentiation between V "a and V # receptors. Protein kinase C is the main cellular target of DAG. Its role in the potentiation between V "a and V # receptors was investigated by using the PKC-activator PMA and its inactive analogue αPDD as a control. As in previous experiments we found that PMA dose-dependently potentiated the V # -related cAMP ac- (Table 5 ). This indicates that the potentiating effect of the V "a vasopressin receptor on the V # receptor-induced cAMP accumulation is mediated by a PMA-sensitive, i.e. PKC-dependent, mechanism.
Cellular target of the potentiation
Phosphodiesterase involvement in the potentiation was assessed by incubating CHO V " V # cells with 1 mM of the phosphodiesterase inhibitor IBMX prior to and during stimulation with hormones or PMA. As expected, IBMX increased the cAMP accumulation resulting from V # receptor stimulation by dDAVP. Neither its presence nor its absence made a difference to the AVP-or PMA-mediated potentiation (Table 4) .
Cyclase involvement was investigated by using the diterpene forskolin, which directly activates the cyclase. In CHO V " V # cells, FSK-induced cAMP accumulation was unaffected by the addition of PMA, in both the absence and presence of IBMX (Table 6) . Similar results were observed in CHO V " cells following their stimulation by forskolin and AVP (data not shown). On the other hand, forskolin not only increased the basal cAMP level in CHO V " V # cells, but also potentiated the dDAVP-induced cAMP accumulation. Forskolin-and AVP-potentiating effects were not additive (Table 7) .
G-protein involvement in the potentiation was assessed by using bacterial toxins which covalently modify either Gα s or Gα i . Cholera toxin ADP-ribosylates the α s subunit, resulting in the inhibition of the intrinsic GTPase activity, stabilization of the activated conformation and sustained cAMP production, while pertussis toxin inactivates the Gα i subunit.
The effect of AVP or PMA on the cholera toxin-induced cAMP accumulation was investigated in CHO V " cells. Cells were pre-incubated with or without cholera toxin at 500 ng\ml for 3 h and were then stimulated with either 10 −) M AVP or 10 −' M PMA. Neither AVP nor PMA modified the cAMP level in unstimulated cells. Both of them enhanced the cholera toxininduced cAMP accumulation ( Table 8 ).
The involvement of Gα i was assessed in CHO V " V # cells. Cells were pre-incubated with pertussis toxin at different concentrations (0n01, 0n1 and 1 µg\ml) for 4 h and then stimulated with dDAVP (10 −) M), or dDAVP and AVP (10 −) M). Pertussis toxin neither enhanced the dDAVP-induced cAMP accumulation, nor modified the AVP-related potentiation (data not shown). This suggests that Gα s protein, but not Gα i , is involved in the potentiation by PKC of the V # -related cAMP production.
DISCUSSION
A complex range of regulatory mechanisms is available for the modulation of cellular cAMP level, and different signal transduction systems may interfere with the cyclase pathway [21] [22] [23] .
In CHO cells transfected with the V "a and the V # vasopressin receptors cDNA, we showed that the V # receptor-induced cAMP accumulation was potentiated by stimulation of the V "a receptor. Since the V "a receptor did not generate any cAMP increase by itself, we presumed that potentiation was related to the effect of V "a receptor second messengers, i.e. calcium and DAG, on the V # receptor and its associated transduction pathway.
As regards the influence of calcium, the absence of extracellular calcium neither affected the dDAVP-induced cAMP accumulation nor its potentiation by AVP. In contrast, chelation of intracellular calcium decreased the cAMP accumulation linked to the stimulation of V # receptor, and abolished the V "a -related potentiation. Calcium chelation also reduced the cAMP accumulation resulting from direct stimulation of the cyclase by forskolin. This indicates that calcium is necessary for the cyclase activity, which could explain the absence of potentiation under calcium chelation conditions. An increase in intracellular calcium induced by thapsigargin did not potentiate cAMP accumulation. On the other hand, DOG, a cell-permeable analogue of diacylglycerol, partially mimicked the potentiating effect of AVP, and thapsigargin somewhat enhanced this effect. Taken together, these data support the hypothesis that production of DAG, subsequent to the V "a receptor stimulation, is directly involved in the potentiation, and that calcium has only a contributory effect. This suggests that protein kinase C is involved in the mechanism of potentiation.
Different results support this hypothesis. Short stimulation with the PKC-activator PMA mimicked the effect of AVP on the dDAVP-induced cAMP accumulation, and the effect of AVP was abolished in the presence of the PKC-inhibitor bisindolylmaleimide, or by long-term PMA pretreatment.
Three PKC isozymes, PKC α, ε and ζ, were identified in CHO cells by Liu et al. [24] . They described a rapid PMA-induced translocation of PKC α and ε from cytosol to membrane, and a drastic down-regulation of PKC α, but not PKC ε, after longterm PMA pretreatment. Thus PKC α could be the PKC isoform involved in the mechanism of potentiation.
A specific interaction between PKC and cAMP signal transduction has been observed in several cell types [25] [26] [27] , and different mechanisms have been described. They include the direct phosphorylation of adenylyl cyclase [10, 11, 28, 29] , the phosphorylation of Gα i , which decreases its ability to inhibit adenylyl cyclase [30, 31] or the regulation of the phosphodiesterases [32] , even if these latter enzymes seem to be preferentially regulated by PKA or CaM-kinases [33] .
The phosphodiesterase pattern in CHO cells has been previously determined [34] . Among the four cAMP-hydrolysing isoforms found in these cells, the major ones are the PDE 4 isoform, which represents 50 % of the total cAMP hydrolysing capacity, and an IBMX-insensitive (possibly PDE 7) isoform, which represents 30 % of total activity. Given the high ratio of these isoforms, inhibition of one of them by calcium or PKC could result in potentiation. It has been previously shown that both fractions are insensitive to calcium [34] . The ability of PKC to inhibit some cAMP phosphodiesterase isoforms has been suggested before [35, 36] . However, such a mechanism is unlikely to be involved in our experimental conditions, for the following reasons. On the one hand, the potentiating effect of AVP or PMA and the effect of the phosphodiesterase inhibitor IBMX were additive, and on the other hand, neither AVP nor PMA potentiated the FSK-induced cAMP accumulation.
Alternatively, our data may correspond to an activation of the cAMP synthesis system, which may be ascribed either to a modification of the cyclase catalytic site or to an enhancement of the coupling between the Gs-protein and the cyclase. As described above, cAMP accumulation in response to the direct cyclase activator forskolin was not enhanced by AVP or PMA. It indicates that the potentiation is not mediated through a mechanism operating on the catalytic activity of the cyclase. This absence of PMA effect on basal and forskolin-stimulated cAMP accumulation is similar to that observed in HT4 cells or in kidney 293 cells transfected with either type I or type VI adenylyl cyclase [10] .
The most specific feature of the potentiation between V "a and V # receptors in CHO cells was that the enhancement of cAMP production by phorbol esters required the coupling between G protein and cyclase. The involvement of Gα s was demonstrated in CHO V " cells, where AVP as well as PMA synergistically increased the cholera toxin-induced cAMP accumulation. The possible implication of Gα i was also investigated because phorbol ester-mediated activation of PKC appeared to abolish the tonic inhibitory effect mediated by Gα i upon adenylyl cyclase in a number of cells [30, 37] . Such a mechanism may be ruled out here, since pertussis toxin did not change the cAMP accumulation induced by V # receptor as its potentiation by V "a receptor. One possible mechanism for the PKC-dependent increase in cAMP production through Gs protein may involve the phosphorylation of the α s subunit and\or the adenylyl cyclase, leading to enhanced reciprocal interaction and sustained activation of the cyclase. This hypothesis has been evoked to explain the synergistic effect of phorbol esters on cAMP production induced by stimulation of the adrenaline receptors in HT4 cells [38] . Another possible mechanism is that enhancement of the coupling would stabilize the catalytic site of the cyclase, resulting in increased cAMP synthesis. Such a stabilization could be similar to the one proposed to explain the potentiation by forskolin of receptor-mediated cAMP accumulation in different cell types [39] [40] [41] . The lack of additivity between AVP-and FSKpotentiating effects on dDAVP-induced cAMP accumulation in CHO V " V # cells would support this hypothesis. In conclusion, stimulation of the PLC pathway via the V "a vasopressin receptor potentiates the cAMP accumulation related to activation of the V # receptor, when these receptors are both expressed in CHO cells. This potentiation results from the activation of PKC, which appears to enhance the coupling between the Gs protein and the adenylyl cyclase. This type of cross-talk, which requires co-activation of the receptors, might contribute to the accuracy of the cellular response at a step upstream of adenylyl cyclases and phosphodiesterases.
